Screener
Olema Pharmaceuticals, Inc. OLMA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
FAQ
- What is Olema Pharmaceuticals, Inc.'s debt-to-equity?
- Olema Pharmaceuticals, Inc. (OLMA) reported debt-to-equity of 0× in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s debt-to-equity changed year-over-year?
- Olema Pharmaceuticals, Inc.'s debt-to-equity decreased by 33.3% year-over-year, from 0× to 0×.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s debt-to-equity has grown at a -31.9% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Olema Pharmaceuticals, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude